Addex highlights strength of allosteric modulation technology platform
Geneva, Switzerland, 12 November 2010 — Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today that data on a total of nine therapeutic programs will be presented during Society for Neuroscience 2010 (November 13-17, San Di…